Xlife Sciences AG / Key word(s): MiscellaneousXlife Sciences portfolio company launches project to research a potential therapy for amyotrophic lateral sclerosis (ALS) 16.01.2023 / 07:00 CET/CESTXlife Sciences' (SIX: XLS) portfolio company inflamed pharma has launched a research project to develop a potential th...
Related Keywords
Germany , Zurich , Züsz , Switzerland , Barop , Nordrhein Westfalen , Talacker , Baden Wüberg , Swiss , Jan Koch , Dennis Lennartz , Janc Koch , Valentin Handschin , Xlife Sciences Ag Key , Department Of Neurology , University Medical Center , Xlife Sciences , Stock Exchange , Swiss Exchange , Chief Scientific Officer , Year Report ,
comparemela.com © 2020. All Rights Reserved.